Cargando…

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

AIMS/HYPOTHESIS: An APOC3 promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether APOC3 polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants. METHODS: In the Rotterdam Study, a populati...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hoek, M., van Herpt, T. W., Dehghan, A., Hofman, A., Lieverse, A. G., van Duijn, C. M., Witteman, J. C. M., Sijbrands, E. J. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088807/ https://www.ncbi.nlm.nih.gov/pubmed/21373834 http://dx.doi.org/10.1007/s00125-011-2092-x

Ejemplares similares

An RBP4 promoter polymorphism increases risk of type 2 diabetes
por: van Hoek, M., et al.
Publicado: (2008)

Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria
por: van Herpt, Thijs T W, et al.
Publicado: (2020)

Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study
por: Dehghan, Abbas, et al.
Publicado: (2008)

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study
por: van Herpt, Thijs T. W., et al.
Publicado: (2016)

Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies : A Population-Based Study
por: van Hoek, Mandy, et al.
Publicado: (2008)

Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study
por: Singh, Sunny S., et al.
Publicado: (2020)

The effect of guideline revisions on vascular complications of type 2 diabetes
por: Heijmans, Ralph, et al.
Publicado: (2019)

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes
por: van Herpt, Thijs T. W., et al.
Publicado: (2017)

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study
por: de Vries, Paul S., et al.
Publicado: (2016)

Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
por: Kozlitina, Julia, et al.
Publicado: (2011)

40 Years of the APOC Partnership
por: Roungou, Jean-Baptist, et al.
Publicado: (2015)

SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity
por: Zillikens, M.Carola, et al.
Publicado: (2009)

IGF-I Bioactivity in an Elderly Population: Relation to Insulin Sensitivity, Insulin Levels, and the Metabolic Syndrome
por: Brugts, Michael P., et al.
Publicado: (2010)

Glycemic Index and Glycemic Load and Their Association with C-Reactive Protein and Incident Type 2 Diabetes
por: van Woudenbergh, Geertruida J., et al.
Publicado: (2011)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Positional OSA part 2: retrospective cohort analysis with a new classification system (APOC)
por: Ravesloot, M. J. L., et al.
Publicado: (2015)

Meat Consumption and Its Association With C-Reactive Protein and Incident Type 2 Diabetes: The Rotterdam Study
por: van Woudenbergh, Geertruida J., et al.
Publicado: (2012)

APOC3 Interference for Familial Chylomicronaemia Syndrome
por: Hegele, Robert A
Publicado: (2022)

Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus
por: Singh, Sunny S., et al.
Publicado: (2020)

APOC3: Triglycerides do matter
por: Hassan, Mohamed
Publicado: (2014)

Eating Fish and Risk of Type 2 Diabetes: A population-based, prospective follow-up study
por: van Woudenbergh, Geertruida J., et al.
Publicado: (2009)

Apolipoprotein E gene is related to mortality only in normal weight individuals: The Rotterdam study
por: Pardo Silva, M. Carolina, et al.
Publicado: (2007)

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis
por: Song, Yongyan, et al.
Publicado: (2015)

Managing the Fight against Onchocerciasis in Africa: APOC Experience
por: Fobi, Grace, et al.
Publicado: (2015)

Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
por: Naber, Annemieke, et al.
Publicado: (2023)

Variance heterogeneity analysis for detection of potentially interacting genetic loci: method and its limitations
por: Struchalin, Maksim V, et al.
Publicado: (2010)

Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels
por: Crawford, Dana C., et al.
Publicado: (2018)

Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study
por: Schuur, M., et al.
Publicado: (2010)

Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Memarian, Elham, et al.
Publicado: (2021)

Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans
por: Rout, Madhusmita, et al.
Publicado: (2022)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus
por: Lemmers, R.F.H., et al.
Publicado: (2021)

Renal Function Is Related to Severity of Coronary Artery Calcification in Elderly Persons: The Rotterdam Study
por: el Barzouhi, Abdelilah, et al.
Publicado: (2011)

ApoC-III is a novel inducer of calcification in human aortic valves
por: Schlotter, Florian, et al.
Publicado: (2021)

Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

A Methodological Perspective on Genetic Risk Prediction Studies in Type 2 Diabetes: Recommendations for Future Research
por: Willems, Sara M., et al.
Publicado: (2011)

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
por: Giammanco, Antonina, et al.
Publicado: (2023)

Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension
por: Sedaghat, Sanaz, et al.
Publicado: (2013)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study
por: Ligthart, Symen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_86ih901bvtlj40rtd3uqsfhotn